| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |